{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:05Z","timestamp":1753891565555,"version":"3.41.2"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsinki University Central Hospital","doi-asserted-by":"publisher","award":["Y780021092","Y780020130","Y780022062","Y780022062","Y780023040"],"award-info":[{"award-number":["Y780021092","Y780020130","Y780022062","Y780022062","Y780023040"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Spinal muscular atrophy, Jokela type (SMAJ) is a rare autosomal dominantly hereditary form of spinal muscular atrophy caused by a point mutation c.197G&amp;gt;T in <jats:italic>CHCHD10<\/jats:italic>. <jats:italic>CHCHD10<\/jats:italic> is known to be involved in the regulation of mitochondrial function even though patients with SMAJ do not present with multiorgan symptoms of mitochondrial disease. We aimed to characterize the cardiopulmonary oxidative capacity of subjects with SMAJ compared to healthy controls and patients with mitochondrial myopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eleven patients with genetically verified SMAJ, 26 subjects with mitochondrial myopathy (MM), and 28 healthy volunteers underwent a cardiopulmonary exercise test with lactate and ammonia sampling. The effect of the diagnosis group on the test results was analysed using a linear model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Adjusted for sex, age, and BMI, the SMAJ group had lower power output (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), maximal oxygen consumption (VO<jats:sub>2<\/jats:sub> max) (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), and mechanical efficiency (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001) compared to the healthy controls but like that in MM. In the SMAJ group and healthy controls, plasma lactate was lower than in MM measured at rest, light exercise, and 30\u2009min after exercise (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001\u20130.030) and otherwise lactate in SMAJ was lower than controls and MM, in longitudinal analysis <jats:italic>p<\/jats:italic>\u2009=\u20090.018. In MM, the ventilatory equivalent for oxygen was higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.040), and the fraction of end-tidal CO<jats:sub>2<\/jats:sub> lower in maximal exercise compared to healthy controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.023) and subjects with SMAJ.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In cardiopulmonary exercise test, subjects with SMAJ showed a similar decrease in power output and oxidative capacity as subjects with mitochondrial myopathy but did not exhibit findings typical of mitochondrial disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1277944","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T16:16:36Z","timestamp":1699546596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Lowered oxidative capacity in spinal muscular atrophy, Jokela type; comparison with mitochondrial muscle disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Nadja","family":"Ratia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Palu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Lantto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Ylikallio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritva","family":"Luukkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Suomalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Piiril\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1212\/WNL.0b013e3182267b71","article-title":"Late-onset lower motor neuronopathy: a new autosomal dominant disorder","volume":"77","author":"Jokela","year":"2011","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/ane.12470","article-title":"Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val","volume":"133","author":"Pasanen","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nmd.2013.11.010","article-title":"Late-onset spinal motor neuronopathy\u2014a common form of dominant SMA","volume":"24","author":"Penttil\u00e4","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"104940","DOI":"10.1016\/j.nbd.2020.104940","article-title":"ALS and Parkinson\u2019s disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons","volume":"141","author":"Harjuhaahto","year":"2020","journal-title":"Neurobiol Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41419-022-04602-5","article-title":"CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response","volume":"13","author":"Ruan","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-014-0421-1","article-title":"Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy","volume":"16","author":"Ajroud-Driss","year":"2015","journal-title":"Neurogenetics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/NXG.0000000000000003","article-title":"(Gly66Val) causes axonal Charcot\u2013Marie\u2013Tooth disease","volume":"1","author":"Auranen","year":"2015","journal-title":"Neurol Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/brain\/awu138","article-title":"A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement","volume":"137","author":"Bannwarth","year":"2014","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1093\/brain\/awu227","article-title":"Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease","volume":"137","author":"M\u00fcller","year":"2014","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"793937","DOI":"10.3389\/fneur.2022.793937","article-title":"Serum creatine, not neurofilament light, is elevated in CHCHD10-linked spinal muscular atrophy","volume":"13","author":"J\u00e4rvilehto","year":"2022","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/brain\/awab411","article-title":"Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy","volume":"145","author":"Habets","year":"2022","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11910-010-0096-4","article-title":"A diagnostic algorithm for metabolic myopathies","volume":"10","author":"Berardo","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1590\/0004-282X20150154","article-title":"When should MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) be the diagnosis?","volume":"73","author":"Lorenzoni","year":"2015","journal-title":"Arq Neuropsiquiatr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11910-016-0652-7","article-title":"Progressive external ophthalmoplegia","volume":"16","author":"McClelland","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref16","first-page":"457","article-title":"Exercise intolerance in patients with McArdle\u2019s disease or mitochondrial myopathies","volume":"1","author":"Chaussain","year":"1992","journal-title":"Eur J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<456::AID-MUS5>3.0.CO;2-B","article-title":"Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia","volume":"19","author":"Dengler","year":"1996","journal-title":"Muscle Nerve"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00415-006-0987-0","article-title":"Lactate increase and oxygen desaturation in mitochondrial disorders\u2013evaluation of two diagnostic screening protocols","volume":"253","author":"Hanisch","year":"2006","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"R873","DOI":"10.1152\/ajpregu.00001.2011","article-title":"Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanisms","volume":"301","author":"Heinicke","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1161\/CIR.0b013e31826fb946","article-title":"EACPR\/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations","volume":"126","author":"Guazzi","year":"2012","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fneur.2016.00082","article-title":"Unique exercise lactate profile in muscle phosphofructokinase deficiency (Tarui disease); difference compared with McArdle disease","volume":"7","author":"Piiril\u00e4","year":"2016","journal-title":"Front Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/2312508X.10010917","article-title":"Determinants of the physiological systems responses to muscular exercise in healthy subjects","volume-title":"Clinical exercise testing","author":"Ward","year":"2018"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/cpf.12817","article-title":"Lactate and ammonia measurements during cardiopulmonary exercise testing and its recovery phase-consideration of age and sex in its interpretation","volume":"43","author":"Ratia","year":"2023","journal-title":"Clin Physiol Funct Imaging"},{"key":"ref24","article-title":"CHCHD10-related disorders","volume-title":"GeneReviews","author":"Ait-El-Mkadem Saadi","year":"2015"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","article-title":"CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study","volume":"14","author":"Funayama","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jnnp-2016-314154","article-title":"CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients","volume":"88","author":"Penttil\u00e4","year":"2017","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/hmg\/ddx393","article-title":"Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS","volume":"27","author":"Straub","year":"2018","journal-title":"Hum Mol Genet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/BST20221365","article-title":"CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy","volume":"51","author":"Shammas","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"8218697","DOI":"10.1155\/2018\/8218697","article-title":"The role of moderate aerobic exercise as determined by cardiopulmonary exercise testing in ALS","volume":"2018","author":"Braga","year":"2018","journal-title":"Neurol Res Int"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"792660","DOI":"10.3389\/fphys.2022.792660","article-title":"Exercise physiology impairments of patients with amyotrophic lateral sclerosis: cardiopulmonary exercise testing findings","volume":"13","author":"He","year":"2022","journal-title":"Front Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JND-140004","article-title":"A randomized, controlled clinical trial of exercise in patients with spinal muscular atrophy: methods and baseline characteristics","volume":"1","author":"Montes","year":"2014","journal-title":"J Neuromuscul Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.108.1.182","article-title":"Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels","volume":"108","author":"Dandurand","year":"1995","journal-title":"Chest"},{"key":"ref33","first-page":"6","article-title":"Mitochondrial myopathy presenting as exercise intolerance","volume":"103","author":"Haller","year":"1978","journal-title":"Trans Am Neurol Assoc"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/jcm10081796","article-title":"Exercise testing, physical training and fatigue in patients with mitochondrial myopathy related to mtDNA mutations","volume":"10","author":"Jeppesen","year":"2021","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1113\/JP279963","article-title":"The anaerobic threshold: 50+ years of controversy","volume":"599","author":"Poole","year":"2021","journal-title":"J Physiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1164\/arrd.1984.129.2P2.S35","article-title":"The anaerobic threshold measurement to evaluate exercise performance","volume":"129","author":"Wasserman","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1038\/s41598-017-02811-z","article-title":"Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in amyotrophic lateral sclerosis during exercise","volume":"7","author":"Lanfranconi","year":"2017","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e0151376","DOI":"10.1371\/journal.pone.0151376","article-title":"Distinct muscle biopsy findings in genetically defined adult-onset motor neuron disorders","volume":"11","author":"Jokela","year":"2016","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/(sici)1097-4598(199710)20:10<1219::aid-mus2>3.0.co;2-f","article-title":"Biochemical and genetic studies in a family with mitochondrial myopathy","volume":"20","author":"Heiman-Patterson","year":"1997","journal-title":"Muscle Nerve"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e157504","DOI":"10.1172\/JCI157504","article-title":"OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy","volume":"132","author":"Shammas","year":"2022","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/brain\/awg028","article-title":"The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients","volume":"126","author":"Taivassalo","year":"2003","journal-title":"Brain"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0140-6736(86)92867-9","article-title":"Controlled study of respiratory responses during prolonged measurement in patients with chronic hyperventilation","volume":"328","author":"Gardner","year":"1986","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0954-6111(96)90156-0","article-title":"Hyperventilation during exercise: independence on exercise-induced bronchoconstriction in mild asthma","volume":"90","author":"Kinnula","year":"1996","journal-title":"Respir Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10072-011-0703-4","article-title":"Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study","volume":"33","author":"Mancuso","year":"2012","journal-title":"Neurol Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"R563","DOI":"10.1152\/ajpregu.2000.278.3.R563","article-title":"Interstitial pH, K+, lactate, and phosphate determined with MSNA during exercise in humans","volume":"278","author":"MacLean","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref46","first-page":"18","volume-title":"Principles of exercise testing and interpretation: including pathophysiology and clinical applications","author":"Wasserman","year":"2012"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1277944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T16:16:42Z","timestamp":1699546602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1277944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":46,"alternative-id":["10.3389\/fneur.2023.1277944"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1277944","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"article-number":"1277944"}}